1st Quarter - Report
THE DUBERSTEIN GROUP INC. for PHRMA INC.
Client
Income
$75,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
IPAB Bill: S 251/Wyden- Protecting Medicare from Executive Action Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN GRIFFIN | — |
Health Issues HCR
American Healthcare Act: HR 1628/Black-American Health Care Act of 2017 Drug Re-importation:S 469/Sanders-Affordable and Safe Prescription Drug Importation Act; HR 1245/Cummings:-Affordable and Safe Prescription Drug Importation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
| ANNE WALL | — |
Budget/Appropriations BUD
Budget Funding Issues: S.Con.Res.3/Enzi (SA 178 not agreed to in Senate 46-52 on 1/11/17)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID J SCHIAPPA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.